Hims vs SkinnyRx: GLP-1 Program Comparison 2026

When comparing Hims vs SkinnyRx for GLP-1 weight loss, Hims offers broader brand recognition and a wider product ecosystem, while SkinnyRx focuses specifically on weight loss with competitive pricing on compounded semaglutide. Both platforms connect you with licensed providers, but they differ in meaningful ways that could affect your results and your wallet.

Quick Comparison Table

Hims Overview

Hims started as a men's health brand focused on hair loss and erectile dysfunction before expanding into weight management. Their GLP-1 program uses the company's established telehealth infrastructure to deliver compounded semaglutide through a subscription model. The platform provides asynchronous provider consultations, meaning you fill out a health questionnaire and a licensed clinician reviews it on their timeline.

One advantage of Hims is their polished mobile app, which bundles weight loss tracking with their other health offerings. If you already use Hims for another service, adding GLP-1 treatment feels smooth. But some users report that the async consultation model can feel impersonal, especially when adjusting doses or managing side effects.

SkinnyRx Overview

SkinnyRx is a weight-loss-specific telehealth platform that built its entire business around GLP-1 medications. Because they specialize in this single vertical, their onboarding process and provider protocols are tuned specifically for metabolic health. SkinnyRx typically offers both compounded semaglutide and tirzepatide options, giving patients more flexibility in their treatment plan.

The platform tends to offer video consultations rather than purely async messaging, which some patients prefer when discussing injection techniques or side effect management. SkinnyRx has grown quickly in the direct-to-consumer weight loss space, though their newer market presence means fewer long-term patient reviews compared to Hims.

Pricing Comparison

Pricing is often the deciding factor for patients choosing between these two platforms. Hims bundles their consultation fee into the monthly subscription, which simplifies budgeting but can make the total cost feel higher upfront. Contact provider for current pricing SkinnyRx tends to price their compounded medications competitively, sometimes offering introductory rates for the first month. Contact provider for current pricing

Neither platform typically accepts insurance for GLP-1 medications, so you'll be paying out of pocket regardless. It's worth asking both providers about their dose escalation pricing, since costs can increase as you move to higher doses of semaglutide or tirzepatide.

Treatment Options

Hims primarily offers compounded semaglutide injections along with some oral weight loss medications. Their formulary is more limited compared to some competitors, but they focus on proven options with strong clinical backing.

SkinnyRx offers a slightly broader medication menu, including both semaglutide and tirzepatide compounds. Tirzepatide (the active ingredient in brand-name Mounjaro and Zepbound) targets both GIP and GLP-1 receptors, which some research suggests may produce greater weight loss in certain patients. Having access to both medication classes gives SkinnyRx patients and their providers more flexibility to find the right fit.

User Experience

Hims wins on brand polish. Their app is well-designed, the packaging looks premium, and the overall experience feels like a consumer tech product. For patients who value a sleek interface and integrated health dashboard, Hims delivers. Customer support is accessible through the app, though response times can vary during peak periods.

SkinnyRx offers a more clinical experience. The platform is functional but less flashy. Where SkinnyRx stands out is in the provider relationship. Patients often report more direct access to their prescribing clinician, which matters when you're titrating doses or working through the nausea and appetite changes that commonly accompany GLP-1 therapy.

Pros and Cons

FormBlends

FormBlends is a U.S. telehealth platform that prescribes compounded semaglutide and tirzepatide. Patients complete an online intake, a licensed provider reviews eligibility, and medication ships from a 503A compounding pharmacy. Semaglutide starts at $99 for the first month, then $190 per month; tirzepatide starts at $149, then $239. Start your intake.

Hims

Pros: Established brand with proven track record. Polished app and user experience. Bundled consultation fees. Wide state availability. Discreet packaging and fast shipping.

Cons: Primarily async consultations can feel impersonal. More limited medication options. Pricing may be higher than weight-loss-only competitors. Less specialized in metabolic health compared to dedicated weight loss platforms.

SkinnyRx

Pros: Weight-loss-focused platform with specialized providers. Offers both semaglutide and tirzepatide. Video consultations available. Competitive pricing on compounded medications.

Cons: Smaller brand with less market history. Limited state availability. Fewer patient reviews available. Less polished digital experience compared to Hims.

Our Verdict

If you want a well-known brand with a smooth digital experience and you're fine with async provider communication, Hims is a solid choice. If you want a platform laser-focused on weight loss with more medication options and the ability to do video consultations with your provider, SkinnyRx may serve you better. Both platforms deliver legitimate GLP-1 treatment through licensed clinicians.

But neither platform offers the depth of physician supervision and personalized compounding that we believe produces the best long-term outcomes. At FormBlends, we pair every patient with a dedicated physician who manages your entire treatment plan, from initial labs through dose improvement and beyond.

What Hims and SkinnyRx actually charge right now (September 2026 price index)

The prices quoted in the sections above were checked when this comparison was written. The table below is different: it is pulled from the FormBlends Compounded GLP-1 Price Index, which records the all-in cash price for a 28-day supply from each provider's public pricing page every week. These are the rows for Hims and SkinnyRx as of September 3, 2026. Month one is the starting dose (2.5 mg tirzepatide or 0.25 mg semaglutide); month four is the first maintenance step (5 mg or 1 mg).

For context, the index median for compounded tirzepatide at month one was $299 across 14 providers on September 3, 2026, and $197 for compounded semaglutide. Brand Zepbound through LillyDirect was $299 to $449 and the Wegovy pen $199 for the first two fills, then $349. The full dataset, methodology and a CSV download are at the Compounded GLP-1 Price Index, where FormBlends is listed under the same rules as every other provider.

Frequently Asked Questions

Is Hims or SkinnyRx cheaper for GLP-1 medication?

SkinnyRx generally offers lower starting prices for compounded semaglutide, though Hims includes consultation fees in their subscription. Total cost depends on your dose and treatment duration. Contact provider for current pricing Contact provider for current pricing

Can I switch from Hims to SkinnyRx mid-treatment?

Yes. Both platforms will conduct their own medical evaluation, but you can share your current dose and treatment history with your new provider to ensure continuity. There's no medical reason you can't switch platforms at any point in your GLP-1 process.

Do Hims and SkinnyRx require lab work before prescribing?

Requirements vary. Hims uses a health questionnaire and may request labs in some cases. SkinnyRx typically reviews your health history during a video consultation. Neither platform universally requires bloodwork before initiating treatment, though thorough lab review is considered best practice.

Are the compounded medications from Hims and SkinnyRx safe?

Both platforms source their compounded medications from licensed 503A or 503B pharmacies regulated by state boards and the FDA. Compounded semaglutide uses the prescribed active pharmaceutical ingredient as brand-name Ozempic and Wegovy.

Sources

1. FormBlends Research. Compounded GLP-1 Price Index, as of September 3, 2026. https://formblends.com/feeds/glp1-prices.json